Decline of serum albumin precedes severe acute GVHD after haploidentical HSCT
نویسندگان
چکیده
Background: Haploidentical hematopoietic stem cell transplantation (HSCT) is a useful therapy for relapsed/refractory acute leukemia or lymphoma because of the strong graft-vs-leukemia (GVL) effect. However, it often accompanied by severe graft-versus-host disease (aGVHD), which most serious complication after haploidentical HSCT. Thus, important to control severity aGVHD while maintaining GVL In our experience pediatric HSCT, takes several days become appearance initial symptoms, mostly skin rashes. this study, we aimed identify biomarkers at onset that predict subsequent development aGVHD. Methods: Forty-five consecutive children with who developed HSCT were enrolled. We analyzed possible from samples collected GVHD. Results: Nineteen patients grade 1–2 aGVHD, and 26 3–4 There was no significant difference in patient characteristics between two groups. Transplant-related mortality occurred only group (34.5%). Multivariate analysis revealed serum albumin an independent biomarker predicting (P = 0.009). The area under receiver operating characteristic curve 0.864. Conclusions: level aGvHD could be
منابع مشابه
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.
We developed an approach of T-cell-replete haploidentical hematopoietic stem cell transplantation (HSCT) with low-dose anti-T-lymphocyte globulin and prospectively compared outcomes of all contemporaneous T-cell-replete HSCT performed at our center using matched sibling donors (MSDs), unrelated donors (URDs), and haploidentical related donors (HRDs). From 2008 to 2013, 90 patients underwent MSD...
متن کاملBone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.
B-cell immune dysfunction contributes to the risk of severe infections after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Delayed B-cell regeneration is found in patients with systemic graft-versus-host disease (GVHD) and is often accompanied by bone marrow (BM) suppression. Little is known about human BM GVHD. We analyzed the reconstitution kinetics of B-cell subsets in adul...
متن کاملPathophysiology of GvHD and Other HSCT-Related Major Complications
For over 60 years, hematopoietic stem cell transplantation has been the major curative therapy for several hematological and genetic disorders, but its efficacy is limited by the secondary disease called graft versus host disease (GvHD). Huge advances have been made in successful transplantation in order to improve patient quality of life, and yet, complete success is hard to achieve. This revi...
متن کاملDonor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
In this study, we tested the efficacy and safety of donor lymphocyte infusion (DLI) with granulocyte colony-stimulating factor (G-CSF) priming in patients who relapsed after haploidentical hematopoietic stem cell transplantation (HSCT). Twenty patients received DLI at a median of 177 days after HSCT. Eight patients survived in complete remission for a median of 1118 days. The 2-year probability...
متن کاملFavorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China
BACKGROUND Since the introduction of tyrosine kinase inhibitors (TKIs) into combination chemotherapy regimens, the majority of newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients have achieved complete remission (CR). However, without allogeneic hematopoietic stem cell transplantation (HSCT), long-term outcomes in adults remain unsatisfactory. Indeed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatrics International
سال: 2021
ISSN: ['1442-200X', '1328-8067', '0374-5600']
DOI: https://doi.org/10.1111/ped.14564